Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease
BackgroundCerebral small vessel disease (CSVD) is associated with the pathogenesis of Alzheimer’s disease (AD). Effective treatments to alleviate AD are still not currently available. Hence, we explored markers and underlying molecular mechanisms associated with AD by utilizing gene expression profi...
Main Authors: | Chun Zou, Xiaohua Huang, Yilong Zhang, Mika Pan, Jieqiong Xie, Liechun Chen, Youshi Meng, Donghua Zou, Jiefeng Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2022.996107/full |
Similar Items
-
Associations of Lipoprotein(a) Level with Cerebral Small Vessel Disease in Patients with Alzheimer’s Disease
by: Nihong Chen, et al.
Published: (2023-12-01) -
Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease
by: Lucong Liang, et al.
Published: (2022-08-01) -
Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
by: Cuihua Zou, et al.
Published: (2023-02-01) -
Biochemical markers of neurodegeneration in patients with cerebral small vessel disease and Alzheimer's disease
by: Larisa A. Dobrynina, et al.
Published: (2023-09-01) -
Cerebral Small Vessel Disease
by: Jakub Litak, et al.
Published: (2020-12-01)